Study outcome | Group | Baseline | Pre-discharge | 6-week follow-up | 12-week follow-up | Group × time | Group | Time | |||||||
M | SD | M | SD | M | SD | M | SD | F | P value | F | P value | F | P value | ||
BMQ-S necessity | Control | 20.56 | 2.45 | 21.44 | 2.76 | 19.75 | 2.67 | 20.25 | 3.89 | 0.70 | 0.558 | 1.87 | 0.182 | 3.68 | 0.024* |
Treatment | 21.20 | 3.40 | 22.38 | 2.75 | 21.83 | 3.10 | 21.69 | 3.55 | |||||||
BMQ-S concerns | Control | 14.50 | 4.75 | 13.94 | 4.74 | 13.81 | 4.18 | 13.00 | 4.77 | 3.30 | 0.035* | 0.35 | 0.560 | 8.06 | 0.001* |
Treatment | 15.33 | 3.87 | 12.35 | 3.41 | 12.60 | 3.91 | 11.72 | 3.91 | |||||||
BMQ-S nec-con diff | Control | 6.06 | 4.99 | 7.50 | 4.63 | 5.94 | 5.84 | 7.25 | 5.72 | 3.62 | 0.026* | 1.32 | 0.260 | 13.65 | 0.001* |
Treatment | 5.62 | 4.96 | 9.85 | 3.89 | 9.28 | 4.61 | 9.75 | 6.40 | |||||||
Necessity 1-item | Control | 8.93 | 1.03 | 9.33 | 1.18 | 8.93 | 1.22 | 8.67 | 1.50 | 0.96 | 0.425 | 1.50 | 0.230 | 2.01 | 0.136 |
Treatment | 9.24 | 1.68 | 9.47 | 0.87 | 9.53 | 0.87 | 9.41 | 1.28 | |||||||
Concerns 1-item | Control | 4.67 | 3.81 | 4.80 | 3.28 | 3.93 | 3.67 | 3.67 | 3.60 | 0.48 | 0.700 | 0.01 | 0.926 | 0.51 | 0.675 |
Treatment | 4.94 | 3.94 | 3.63 | 3.93 | 4.31 | 3.65 | 3.81 | 3.80 | |||||||
Self-efficacy 1-item | Control | 8.67 | 1.88 | 9.33 | 0.98 | 9.13 | 0.83 | 9.40 | 0.74 | 1.39 | 0.267 | 0.92 | 0.344 | 2.70 | 0.065 |
Treatment | 7.88 | 2.42 | 8.53 | 2.15 | 9.53 | 0.87 | 9.12 | 1.50 | |||||||
Timeline 1-item | Control | 9.50 | 1.61 | 9.57 | 1.16 | 8.86 | 1.99 | 9.57 | 0.85 | 3.04 | 0.046* | 0.15 | 0.703 | 0.37 | 0.776 |
Treatment | 8.76 | 2.19 | 9.06 | 1.78 | 9.59 | 0.80 | 9.47 | 1.33 | |||||||
MARS-5 total | Control | – | – | – | – | 24.38 | 1.16 | 24.67 | 0.66 | 2.72 | 0.108 | 0.08 | 0.775 | 0.00 | 0.982 |
Treatment | – | – | – | – | 24.72 | 0.46 | 24.44 | 0.86 | |||||||
MARS-5 - UNA | Control | – | – | – | – | 4.52 | 0.68 | 4.71 | 0.64 | 2.59 | 0.116 | 0.06 | 0.807 | 0.02 | 0.881 |
Treatment | – | – | – | – | 4.74 | 0.45 | 4.58 | 0.61 | |||||||
MARS-5 - INA | Control | – | – | – | – | 19.86 | 0.65 | 19.95 | 0.22 | 1.12 | 0.296 | 0.17 | 0.679 | 0.01 | 0.935 |
Treatment | – | – | – | – | 20.00 | 0.00 | 19.89 | 0.47 |
BMQ-S, beliefs about medicines questionnaire-specific; Concerns 1-item, single-item measuring concerns; INA, intentional non-adherence; MARS, medication adherence report scale; nec-con diff, necessity-concerns differential; Necessity 1-item, single-item measuring necessity; Self-efficacy 1-item, single item measuring medicines-related self-efficacy; Timeline 1-item, single-item measuring perceived illness duration; UNA, unintentional non-adherence.